{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "SNCA A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkinson disease (PD) is characterized by the formation of intracellular protein inclusions called Lewy bodies that contain α-synuclein (αSyn) in an amyloid conformation. The truncation of αSyn by proteolytic events contributes to its aggregation and cytotoxicity.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism is clearly defined as the formation of Lewy bodies with αSyn in an amyloid conformation, leading to neurodegeneration."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study evaluates the effect of disease-associated mutations on αSyn's fragmentation, conformation, and association reactions in the presence of the 20S proteasome and liposomes.",
          "judgment": "Yes",
          "reasoning": "The assays (proteasomal cleavage and liposome binding) are relevant to the defined disease mechanism involving αSyn aggregation and toxicity."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The study demonstrates that all mutant αSyns (A30P, E46K, A53T) are cleaved by the 20S proteasome and form amyloid fibrils. The wildtype protein also forms soluble oligomers, which are cytotoxic.",
          "judgment": "Yes",
          "reasoning": "The study includes controls (wildtype αSyn) and demonstrates consistent results across multiple experiments."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The A30P mutation accelerates the formation of soluble, cytotoxic oligomers in the presence of both proteasome and liposomes.",
          "judgment": "Yes",
          "reasoning": "The functional data for A30P directly correlates with its role in PD pathogenesis."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The A30P mutation accelerates the formation of cytotoxic αSyn oligomers, providing supporting evidence for its pathogenic role in PD."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "E",
          "alt": "K",
          "position": "46"
        },
        "variant_string_id": "SNCA E46K"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkinson disease (PD) is characterized by the formation of intracellular protein inclusions called Lewy bodies that contain α-synuclein (αSyn) in an amyloid conformation. The truncation of αSyn by proteolytic events contributes to its aggregation and cytotoxicity.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism is clearly defined as the formation of Lewy bodies with αSyn in an amyloid conformation, leading to neurodegeneration."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study evaluates the effect of disease-associated mutations on αSyn's fragmentation, conformation, and association reactions in the presence of the 20S proteasome and liposomes.",
          "judgment": "Yes",
          "reasoning": "The assays (proteasomal cleavage and liposome binding) are relevant to the defined disease mechanism involving αSyn aggregation and toxicity."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The study demonstrates that all mutant αSyns (A30P, E46K, A53T) are cleaved by the 20S proteasome and form amyloid fibrils. The wildtype protein also forms soluble oligomers, which are cytotoxic.",
          "judgment": "Yes",
          "reasoning": "The study includes controls (wildtype αSyn) and demonstrates consistent results across multiple experiments."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The E46K mutation accelerates the formation of cytotoxic αSyn oligomers in the presence of both proteasome and liposomes.",
          "judgment": "Yes",
          "reasoning": "The functional data for E46K directly correlates with its role in PD pathogenesis."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The E46K mutation accelerates the formation of cytotoxic αSyn oligomers, providing supporting evidence for its pathogenic role in PD."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "53"
        },
        "variant_string_id": "SNCA A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkinson disease (PD) is characterized by the formation of intracellular protein inclusions called Lewy bodies that contain α-synuclein (αSyn) in an amyloid conformation. The truncation of αSyn by proteolytic events contributes to its aggregation and cytotoxicity.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism is clearly defined as the formation of Lewy bodies with αSyn in an amyloid conformation, leading to neurodegeneration."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study evaluates the effect of disease-associated mutations on αSyn's fragmentation, conformation, and association reactions in the presence of the 20S proteasome and liposomes.",
          "judgment": "Yes",
          "reasoning": "The assays (proteasomal cleavage and liposome binding) are relevant to the defined disease mechanism involving αSyn aggregation and toxicity."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The study demonstrates that all mutant αSyns (A30P, E46K, A53T) are cleaved by the 20S proteasome and form amyloid fibrils. The wildtype protein also forms soluble oligomers, which are cytotoxic.",
          "judgment": "Yes",
          "reasoning": "The study includes controls (wildtype αSyn) and demonstrates consistent results across multiple experiments."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The A53T mutation accelerates the formation of cytotoxic αSyn oligomers in the presence of both proteasome and liposomes.",
          "judgment": "Yes",
          "reasoning": "The functional data for A53T directly correlates with its role in PD pathogenesis."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The A53T mutation accelerates the formation of cytotoxic αSyn oligomers, providing supporting evidence for its pathogenic role in PD."
    }
  ]
}